Skip to content

Effects of Acupuncture and Moxibustion on Heart Rate Variability in Patients with Chronic Fatigue Syndrome

A Randomized Control Trial of Acupuncture and Moxibustion on Chronic Fatigue Syndrome and Heart Rate Variability

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007383
Enrollment
Unknown
Registered
2015-11-12
Start date
2014-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Interventions

acupuncture group:acupuncture at ST36, CV4
moxibustion:moxibustion at ST36, CV4
control group:acupuncture at ST36, CV4

Sponsors

Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture & Moxibustion; Acupuncture & Moxibustion Institute, Hubei University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with CFS who were 18 to 65 years old; 2. Patients who met the diagnostic criteria for CFS that were published by the Centers for Disease Control and Prevention in the United States; 3. Patients who had no skin injuries at the acupoints (ST36 (Zusanli), CV4 (Guanyuan)).

Exclusion criteria

Exclusion criteria: 1. Participants who could not accept and were afraid of acupuncture in the acupuncture group; 2. Participants who suffered from heart and cerebrovascular diseases, serious lung disease, diabetes, neurological diseases, or severe primary diseases such as those of the liver, kidney, and the hematopoietic system; 3. Participants who suffered from a mental health disorder, Alzheimer's disease, or cancer; 4. Participants who had taken Chinese herbal medicine during the previous 4 weeks and preceding the investigation; 5. Pregnant women and nursing mothers; 6. Participants who suffered from thrombocytopenia and abnormalities of blood coagulation; 7. Participants with a history of alcohol or drug abuse.

Design outcomes

Primary

MeasureTime frame
Fatigue Assessment Instrument;

Secondary

MeasureTime frame
mean HR;SDNN;total HRV;LF;HF;lg LF/HF;

Countries

Austria

Contacts

Public ContactFengxia LIang
fxliang5@hotmail.com+86 18971371818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026